Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Merck/Berzosertib shows positive results.
https://www.foxnews.com/health/first-in-class-precision-cancer-drug-shows-promising-results-in-phase-i-trial
TTPH—(+69%/AH)—receives unsolicited buyout offer from LJPC that trumps ACRX’s buyout deal announced on 3/16/20 (#msg-154357912):
https://www.sec.gov/Archives/edgar/data/920465/000092046520000067/exhibitfy20tetraphase.htm
Quote:
On behalf of La Jolla Pharmaceutical Company, I am pleased to submit this non-binding proposal to acquire 100% of the equity of Tetraphase Pharmaceuticals, Inc. for $22 million in cash plus an additional $12.5 million potentially payable under CVRs to be issued in the transaction. The $22 million upfront consideration would include amounts payable under the Black-Scholes put provisions in Tetraphase’s outstanding warrants and be subject to a minimum, to-be-agreed-upon closing net cash balance.
The terms of the CVRs would match those set forth in Tetraphase’s merger agreement with AcelRx Pharmaceuticals, Inc., except that payments pursuant to the CVRs would be made in cash instead of cash or stock at the acquiror’s option.
Wonder how this will go over?
https://www.yahoo.com/news/frontier-airlines-passengers-pay-extra-145900513.html
New Ventilator $1000 FDA approval
https://www.yahoo.com/news/fda-authorizes-production-ventilator-costs-182643749.html
Link to the virus stats that updates by the hour. State by state.
https://www.worldometers.info/coronavirus/country/us/
Looks like Mitch Brown has a few years to go. Is he on anyone's friends list? Maybe we should send him some pizza cones.
INMATE NAME & REGISTER NUMBER
USP Lewisburg
U.S. PENITENTIARY
P.O. BOX 1000
LEWISBURG, PA 17837
Name: MITCHELL BROWN
Register Number: 66744-050
Age: 51
Race: White
Sex: Male
Release Date: 09/21/2019
Located At: USP Lewisburg
"but things are different this time. REALLY!!!"
Only thing different is a new group of SUCKERS!
I have seen this before with IMGG. I notified the SEC and as time went on an investigation started. SEC found that the CEO lied to shareholders on another subject. The vote count being off was a red flag to me.
Looks like the rest of Mitchell Browns crew are going to prison with him.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128514435
At some point they will LOCK the board. History will still be there, but wont allow any further post.
Yes, the Russian finaly finished the programing lmao
He brought Dane on because the SEC will no longer allow Dean Janes to be CEO or a board member of any company ever again! ScAM me once your bad. SCAM me twice my bad. No way I would invest in this company!
Personaly I think Dean Janes should have surved time in prison for his action!!
I know you remember our friend that lost 250,000 to Dean Janes crooked way!!
Did your friends that followed you into the Janes Scam ever recover?
Probably none of the old timers. I pulled the eject Handel on the offer day.
2DaMoon
How much does 1 Million Dollars weigh? I only know of one other here that could answer that question??
You can obtain a copy of the CRL through the Feedon of information act. Sounds like they have something to hide?
Want to congratulate all here that held especially the old timers. The new holders probably don't recognize me. I moderated this board at one time. I held through the Harvey Burger and board of directors ineptness.
A special Thank You for all you have done for this forum 2damoon. It's been a long road but we reached it just as you said. I appreciate you exposing the former CEO and board of directors. You call it as it is. Good or bad.
Oh the show run by the Goat Farmer?
Cono Italiano is delinquent on SEC filings. They have not filed since 2014. We don't even know who to Mitch Browns place when he went to Prison.
http://www.otcmarkets.com/stock/CNOZ/filings
CJAKE1
Who's the CEO NOW?
Being he is on the Board of directors he would have to file with the SEC prior to sell date!
What Inmates really eat in Prison. NO PIZZA CONES
http://www.msn.com/en-us/foodanddrink/foodculture/what-inmates-really-eat-in-prison/ss-BBwxWgs?li=BBnbfcL#image=1
I remember this guy. I'm getting OLD.
Well Mitch Brown reported to the Bureau of Prisons on Tuesday. I wonder if they serve pizza cones in his facility?
Any one seen Dean Janes Grave? I didn't think so!Let me guess, he was buried in the far east. Next we will here he was on flight 370.
It can't be Friends and Family, they have already been raped or made thier cash and ran.
They were attempting to run this pump and dump one more time. Since the SEC ruling that's next to impossible. Didn't stop them from trying. The creditors Wont have much when they do take all the assets unless they need a write off for taxes.
The only Dreams I had with ARIA were living nightmares!
Sounds like a few are trying to line their pockets before the liquidation of the company.
Latest from Judge William Young
scion Member Level Tuesday, 07/12/16 09:45:57 AM
Re: scion post# 109524
Post # of 110409
Pacer update 29 Jun 16 - USA v. Affa et al CRIMINAL DOCKET FOR CASE #: 1:14-cr-10221
https://ecf.mad.uscourts.gov/cgi-bin/iquery.pl
CRIMINAL DOCKET FOR CASE #: 1:14-cr-10221-WGY All Defendants
Case title: USA v. Affa et al
Magistrate judge case numbers: 1:14-mj-01051-RBC
1:14-mj-01052-RBC
1:14-mj-01053-RBC
1:14-mj-07112-JCB
Date Filed # Docket Text
06/22/2016 192 Judge William G. Young: ORDER entered. STATEMENT OF REASONS as to Mitchell Brown. (Gaudet, Jennifer) (Entered: 06/29/2016)
United States District Court
District of Massachusetts (Boston)
CRIMINAL DOCKET FOR CASE #: 1:14-cr-10221-WGY All Defendants
Case title: USA v. Affa et al
Magistrate judge case numbers: 1:14-mj-01051-RBC
1:14-mj-01052-RBC
1:14-mj-01053-RBC
1:14-mj-07112-JCB
Date Filed: 07/23/2014
Assigned to: Judge William G. Young
Defendant (1)
Michael Affa
TERMINATED: 02/19/2016
also known as
Michael A. Affa
TERMINATED: 02/19/2016
represented by Robert M. Goldstein
20 Park Plaza, Suite 1000
Boston, MA 02116
617-742-9015
Fax: 617-742-9016
Email: rmg@goldstein-lawfirm.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Retained
Pending Counts
Disposition
18:371...CONSPIRACY TO COMMIT SECURITIES FRAUD AND WIRE FRAUD
(1) The defendant is sentenced to 33 months in custody of Bureau of Prisons on each count, each count to run concurrently with each other, to be followed by 36 months of supervised release with standard and special conditions. $700 special assessment. $1,000,000 fine.
15:78j(b), 78(ff); 17 C.F.R. SEC. 240.10b5; AND 18:2...SECURITIES FRAUD
(2) The defendant is sentenced to 33 months in custody of Bureau of Prisons on each count, each count to run concurrently with each other, to be followed by 36 months of supervised release with standard and special conditions. $700 special assessment. $1,000,000 fine.
18:1343, 1349, AND 2...WIRE FRAUD
(3-7) The defendant is sentenced to 33 months in custody of Bureau of Prisons on each count, each count to run concurrently with each other, to be followed by 36 months of supervised release with standard and special conditions. $700 special assessment. $1,000,000 fine.
Highest Offense Level (Opening)
Felony
Terminated Counts
Disposition
None
Highest Offense Level (Terminated)
None
Complaints
Disposition
18:371 - CONSPIRACY
Assigned to: Judge William G. Young
Defendant (2)
Andrew Affa
also known as
Andrew J. Affa
represented by Steven E. Losquadro
649 Route 25A
Suite 4
Rocky Point, NY 11778
631-744-9070
Fax: 631-744-9421
Email: losquadrolaw@aol.com
LEAD ATTORNEY
PRO HAC VICE
ATTORNEY TO BE NOTICED
Designation: Retained
William H. Connolly
Law Offices of William H. Connolly
20 Park Plaza
Suite 1000
Boston, MA 02210
617-542-0200
Email: whc@williamconnollylaw.com
ATTORNEY TO BE NOTICED
Designation: Retained
Pending Counts
Disposition
18:371...CONSPIRACY TO COMMIT SECURITIES FRAUD AND WIRE FRAUD
(1)
15:78j(b), 78(ff); 17 C.F.R. SEC. 240.10b5; AND 18:2...SECURITIES FRAUD
(2)
18:1343, 1349, AND 2...WIRE FRAUD
(3-7)
Highest Offense Level (Opening)
Felony
Terminated Counts
Disposition
None
Highest Offense Level (Terminated)
None
Complaints
Disposition
18:371 - CONSPIRACY
Assigned to: Judge William G. Young
Defendant (3)
Mitchell Brown
TERMINATED: 06/22/2016
also known as
Mitchell H. Brown
TERMINATED: 06/22/2016
represented by Richard Roth
The Roth Law Firm, PLLC
295 Madison Avenue
Floor 22
New York, NY 10017
(212) 542-8882
Fax: (212) 542-8883
Email: rich@rrothlaw.com
LEAD ATTORNEY
PRO HAC VICE
ATTORNEY TO BE NOTICED
Designation: Retained
Danielle Pomeraniec
The Roth Law Firm, PLLC
295 Madison Avenue
Floor 22
New York, NY 10017
(212) 542-8882
Fax: (212) 542-8883
Email: danielle@rrothlaw.com
TERMINATED: 06/01/2015
PRO HAC VICE
ATTORNEY TO BE NOTICED
Designation: Retained
Robert S. Messinger
Nystrom Beckman & Paris LLP
One Marina Park Drive, 15th Flr.
Boston, MA 02210
617-778-9104
Fax: 617-778-9110
Email: robert.messinger@gmail.com
ATTORNEY TO BE NOTICED
Designation: Retained
Pending Counts
Disposition
18:371...CONSPIRACY TO COMMIT SECURITIES FRAUD AND WIRE FRAUD
(1) The defendant is committed to the custody of BOP for 42 months on each count, each count to run concurrently with each other and with term imposed in case 15-cr-10297-WGY. Three years of supervised release with standard and special conditions. $900 total special assessment (combined with 15-cr-10297). $1 Million fine.
15:78j(b), 78(ff); 17 C.F.R. SEC. 240.10b5; AND 18:2...SECURITIES FRAUD
(2) The defendant is committed to the custody of BOP for 42 months on each count, each count to run concurrently with each other and with term imposed in case 15-cr-10297-WGY. Three years of supervised release with standard and special conditions. $900 total special assessment (combined with 15-cr-10297). $1 Million fine.
18:1343, 1349, AND 2...WIRE FRAUD
(3-7) The defendant is committed to the custody of BOP for 42 months on each count, each count to run concurrently with each other and with term imposed in case 15-cr-10297-WGY. Three years of supervised release with standard and special conditions. $900 total special assessment (combined with 15-cr-10297). $1 Million fine.
Highest Offense Level (Opening)
Felony
Terminated Counts
Disposition
None
Highest Offense Level (Terminated)
None
Complaints
Disposition
18:371 - CONSPIRACY
Assigned to: Judge William G. Young
Defendant (4)
Christopher Putnam
also known as
Christopher R. Putnam
represented by Joshua Robert Hanye
Federal Public Defender's Office
5th Floor
51 Sleeper Street
Boston, MA 02210
617-223-8061
Email: joshua_hanye@fd.org
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Public Defender or Community Defender Appointment
Pending Counts
Disposition
18:371...CONSPIRACY TO COMMIT SECURITIES FRAUD AND WIRE FRAUD
(1)
15:78j(b), 78(ff); 17 C.F.R. SEC. 240.10b5; AND 18:2...SECURITIES FRAUD
(2)
18:1343, 1349, AND 2...WIRE FRAUD
(3-7)
Highest Offense Level (Opening)
Felony
Terminated Counts
Disposition
None
Highest Offense Level (Terminated)
None
Complaints
Disposition
18 U.S.C. § 371 Conspiracy to Commit Securities Fraud.
Assigned to: Judge William G. Young
Defendant (5)
Christopher Nix
also known as
Gabe Nix
also known as
Christopher G. Nix
represented by Jonathan L. Kotlier
Nutter, McClennen & Fish, LLP
Seaport West
155 Seaport Boulevard
Boston, MA 02210-2604
617-439-2000
Fax: 617-310-9683
Email: jkotlier@nutter.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Retained
Andrew R. McArdell
Nutter, McClennen & Fish, LLP
Seaport West
155 Seaport Boulevard
Boston, MA 02210-2604
617-439-2339
Email: amcardell@nutter.com
ATTORNEY TO BE NOTICED
Designation: Retained
Pending Counts
Disposition
18:371...CONSPIRACY TO COMMIT SECURITIES FRAUD AND WIRE FRAUD
(1)
15:78j(b), 78(ff); 17 C.F.R. SEC. 240.10b5; AND 18:2...SECURITIES FRAUD
(2)
18:1343, 1349, AND 2...WIRE FRAUD
(3-7)
Highest Offense Level (Opening)
Felony
Terminated Counts
Disposition
None
Highest Offense Level (Terminated)
None
Complaints
Disposition
18 U.S.C. § 371 Conspiracy to Commit Securities Fraud.
Plaintiff
USA
represented by Eric A. Forni
United States Attorney's Office MA
Suite 9200
1 Courthouse Way
Boston, MA 02210
617-573-8827
Email: eric.forni@usdoj.gov
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Assistant US Attorney
Vassili Thomadakis
US Attorney's Office - MA
J. Joseph Moakley U.S. Courthouse
1 Courthouse Way
Suite 9200
Boston, MA 02210
617-748-3105
Email: vassili.thomadakis@usdoj.gov
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Assistant US Attorney
Andrew J. Palid
Securities and Exchange Commission - MA
33 Arch Street
23rd Floor
Boston, MA 02110-1424
(617) 573-4540
Email: palida@sec.gov
ATTORNEY TO BE NOTICED
https://ecf.mad.uscourts.gov/cgi-bin/iquery.pl
You can bet some of them are still lurking around! Dean is not dead!
BuyOnDips Member Level Friday, 07/08/16 10:10:23 AM
Re: None
Post # of 110275
scion Member Level Friday, 07/08/16 09:58:31 AM
Re: None
Post # of 110273
Theranos Founder, Elizabeth Holmes, Is Barred From Running Lab for 2 Years
The New York Times By CARLOS TEJADAJULY 8, 2016
http://goo.gl/PtpqPp
United States regulators have banned Elizabeth Holmes, the chief executive of Theranos, from owning or operating a medical laboratory for at least two years, in a major setback for the embattled blood-testing start-up and its once widely lauded founder.
In a statement late Thursday, Theranos said the regulators revoked the certification of its Newark, Calif., laboratory and prohibited the laboratory from taking Medicare and Medicaid payments for its services. Regulators also levied a monetary penalty that Theranos did not specify. The sanctions take effect in 60 days, Theranos said.
Theranos represents the promise and the pitfalls of the start-up era, as money floods into young companies with new technologies in an effort to find a “unicorn” — a billion-dollar business that transforms its industry and makes its backers rich in the process. The high-profile start-up rose to prominence on the promise that it could detect health ailments by testing blood drawn cheaply by the mere prick of a finger.
The government scrutiny stemmed from questions about the effectiveness of Theranos’s technology and the way it operates its labs. Authorities who reviewed its practices last year found that all 81 patient results they inspected were inaccurate in a test of blood clotting administered from April to September on patients who take the blood thinner warfarin.
What Theranos and Ms. Holmes will do next is not clear. Lab operators have the right to appeal a canceled certification. Reached via email, an outside spokesman for the company declined to comment.
“We accept full responsibility for the issues at our laboratory in Newark, Calif., and have already worked to undertake comprehensive remedial actions,” Ms. Holmes said in a statement.
Theranos and its young founder in particular offered a compelling narrative in the crowded start-up universe: a brilliant college dropout with an audacious idea that would upend the medical testing business. Ms. Holmes invited comparisons to the Apple co-founder Steve Jobs because of her youth, her tight control of the company she founded and even her customary black turtleneck sweaters.
Ms. Holmes began the company in 2003 after dropping out of Stanford University at the age of 19. Her goal was to create a new way to perform blood tests that relied on a few drops of blood rather than the larger amounts medical testing often requires. Tests would be cheaper, the argument went, and more people would be inclined to get them. In interviews focused on Theranos’s success, she said the idea came from her fear of needles.
The idea had appeal. Theranos won backing from tech luminaries like the software mogul Larry Ellison, while the company counted Henry Kissinger, the former secretary of state, and the former Senate majority leader Bill Frist among its advisers. It also struck a deal with Walgreens, the drugstore chain, to perform tests. By last year, the company had assembled an eminent board of directors and commanded a valuation of about $9 billion.
But some people questioned the reliability of the tests, including former Theranos employees who took their concerns to federal regulators. Ms. Holmes defended the company publicly, especially after articles last year in The Wall Street Journal enumerated those concerns.
Still, federal inspectors found deficiencies in the Newark plant that could lead to inaccurate results, including inadequately trained employees and samples stored at the wrong temperature. Theranos promised to overhaul the plant and bring in a new slate of experts to fix its problems. Then, in April, Theranos said it was under criminal investigation from the United States Justice Department and disclosed another inquiry from the Securities and Exchange Commission.
As the scrutiny mounted, Theranos faced a cascade of problems. The company’s chief operating officer resigned and its alliance with Walgreens fell apart.
The sanctions disclosed on Thursday were leveled by the Centers for Medicare and Medicaid Services, an arm of the United States Department of Health and Human Services that regulates laboratory testing performed on humans.
In its statement, Theranos said it would shut down and rebuild its Newark lab “from the ground up” and bolster its personnel and training there. Theranos said it would stop patient testing at the Newark facility immediately, before the sanctions take effect in 60 days. The company will continue to offer services through its lab in Arizona, it said.
The company was “disappointed” with the decision, Ms. Holmes said in the statement, adding that Theranos was committed “to demonstrating our dedication to the highest standards of quality and compliance.”
Correction: July 8, 2016
An earlier version of this article misstated the results of a review last year of practices at a Theranos lab. Authorities found that all patient results from a particular blood-clotting test administered from April to September were inaccurate; they did not find that all patient test results were inaccurate.
DewDiligence Member Level Thursday, 06/30/16 09:47:33 AM
Re: DewDiligence post# 202227
Post # of 202286
Recent Biotech Buyouts of Publicly Traded Companies
[Added OPK-TTHI.]
Acquired ‡Premium *Deal iHub
Company Buyer to Market Value Date Reference
AVRX CLDA 487% $8M 10/08 #msg-33212809
GNLB GSK 465% $57M 10/08 #msg-33209281
MEMY Roche 319% $50M 11/08 #msg-33787598
ANDS Roche 256% $220M 10/11 #msg-68043946
SYNB PFE 240% $10M 12/10 #msg-58221573
IDIX MRK 239% $3.85B 6/14 #msg-103051902
KOSN BMY 233% $190M 5/08 #msg-29647147
NSPH LMNX 179% $77M 5/16 #msg-122867416
MGRM LH 171% $155M 6/09 #msg-38960958
COLY PFE 167% $165M 11/07 #msg-24600805
INHX BMY 163% $2.5B 1/12 #msg-70636307
CYPB Ramius 160% $255M 12/10 #msg-57780859
NTMD Deerfld z158% z$36M 1/09 #msg-35132470
ICGN PFE 150% $56M 7/11 #msg-65365128
EYE ABT 149% $2.8B 1/09 #msg-34762429
IOMI Intercell 147% $190M 5/08 #msg-29232165
CPEX FCB Hldgs 142% $77M 3/11 #msg-61326856
GEVA ALXN 136% $8.4B 5/15 #msg-113395760
BTRX Stiefel 136% $150M 6/08 #msg-30201906
ISTA Bausch&Lm 134% $500M 3/12 #msg-73708628
SOMX PTX 127% $25M 12/12 #msg-82334111
Tepnel GPRO 126% $132M 1/09 #msg-35221710
INSV Sun Phrma 125% $48M 9/15 #msg-116997898
TTHI OPK 121% $60 6/16 #msg-123621440
ADLR CBST 121% $190M 10/11 #msg-68264754
SGXP LLY 119% $64M 7/08 #msg-30547648
ENCY PFE 118% $350M 2/08 #msg-26978155
ICEL Fujifilm 108% $307M 3/15 #msg-112226224
TRCA Ipsen 104% $660M 6/08 #msg-29795183
AMLN BMY 101% u$7.0B 6/12 #msg-77122453
HGSI GSK 99% $3.0B 7/12 #msg-77532608
CRY.to MDT 97% $380M 9/08 #msg-32421462
BITI ACOR 94% $363M 1/16 #msg-119923883
Speedel NVS 94% $880M 7/08 #msg-30588524
HTWR MDT 93% $1.1B 6/16 #msg-123551339
MEDA.ST MYL 92% $9.9B 2/16 #msg-120456111
MNT JNJ 92% $1.1B 11/08 #msg-33879830
OCAT Astellas 91% $379M 11/15 #msg-118374922
MEDX BMY 90% $2.1B 7/09 #msg-39801273
VRUS GILD 89% $11B 11/11 #msg-69211700
AGN ACT q88% $66B 11/14 #msg-108238424
OMTH AZN 88% $260M 5/13 #msg-88349427
MAKO SYK 86% $1.65B 9/13 #msg-92358712
SIRT GSK 85% $620M 4/08 #msg-28705020
ZGEN BMY 84% $885M 9/10 #msg-54152162
AMBI Dai.Sankyo 83% $315M 9/14 #msg-106688411
TRIV ELGX 81% $211M 10/15 #msg-118008485
YMI GILD 81% $510M 12/12 #msg-82377008
ORIDN.SW COV 77% $300M 4/12 #msg-74079493
CVTX GILD 76% $1.4B 3/09 #msg-36225695
MOVET.BR Shire 74% $560M 8/10 #msg-52918245
IDEV ENDP 74% $370M 1/09 #msg-34592416
CPXX JAZZ 73% $1.5B 5/16 #msg-122995888
LEVP VPHM y73% y$510M 7/08 #msg-30704409
TARG MDCO 72% $42M 1/09 #msg-34774402
Ventana Roche 72% $3.4B 1/08 #msg-30912677
Jerini Shire 71% $520M 7/08 #msg-30452872
APNO Cell Bio 70% $20M 9/09 #msg-43348606
AAH.AX CEPH 69% $207M 2/09 #msg-35956544
DDS.TO PLB.TO 68% $15M 8/11 #msg-66272770
ALXA Gp Ferrer 67% $20M 5/16 #msg-122522140
DRTX ACT 66% $675M 10/14 #msg-106925472
LPDX LH 65% $83M 9/14 #msg-106598786
OSTE MDT 65% $123M 8/10 #msg-53410183
TLCR Grifols 64% $3.4B 6/10 #msg-50961841
FACT ABT 64% $450M 3/10 #msg-47606240
Acambis SNY 64% $550M 7/08 #msg-30990498
JAV HSP 64% $141M 4/10 #msg-48881292
Synthes JNJ 61% $21.5B 4/11 #msg-62473819
SCRX Shionogi 61% $1.4B 9/08 #msg-31859174
XNPT Arbor Phrm 60% $487M 5/16 #msg-122847495
BRLI OPK 60% $1.5B 6/15 #msg-114296569
MAPP AGN 60% $958M 1/13 #msg-83696395
BFRM Merz 60% $253M 1/10 #msg-45071380
CXS.AX CEPH 59% $163M 3/11 #msg-61453144
CRXL JNJ 58% $2.4B 12/10 #msg-57504349
VOLC PHG 57% $1.0B 12/14 #msg-109142343
MEDS XON 57% $26M 12/13 #msg-95175483
OMPI VRX 56% $360M 3/13 #msg-86332513
BMTI WMGI 56% $380M 12/12 #msg-81626598
MTXX HIG Captl 56% $75M 12/10 #msg-57778844
ASPM COV 56% $210M 9/09 #msg-43348479
ANAC PFE 55% $5.2B 5/16 #msg-122659881
RNA BMRN 55% $840M 11/14 #msg-108456369
AUXL ENDP 55% $2.6B 10/14 #msg-107031514
OSIP Astellas 55% $4.0B 5/10 #msg-50234451
IDMI Takeda 55% $75M 5/09 #msg-37898204
GNOM BGI-Shnzhn 54% $118M 9/12 #msg-79636464
RDEA AZN 54% $1.3B 4/12 #msg-74706626
BSMD MMSI 54% $96M 5/10 #msg-50161877
ATSI MDT 54% $370M 4/10 #msg-49617936
ALO KG 54% $1.6B 11/08 #msg-33763449
ABGX AMGN 54% $2.2B 12/05 #msg-8876857
MEDI AZN 53% $15.2B 4/07 #msg-19020387
MLNM Takeda 53% $8.8B 4/08 #msg-28365383
AFFX TMO 52% $1.3B 1/16 #msg-119712743
TRBN EBS 52% $97M 8/10 #msg-53271836
SYNO BAX 52% $260M 12/11 #msg-69906294
PCOP LGND 52% $75M 9/08 #msg-32404474
ALR ABT 51% $8.4B 2/16 #msg-120217001
NPSP SHPG 51% $5.2B 1/15 #msg-109811213
CLZR ELOS 51% $65M 9/09 #msg-41293512
OMRI JNJ 51% $465M 11/08 #msg-33762745
IMCL LLY 51% $6.5B 10/08 #msg-32662830
PSTX SYK 50% $120M 1/14 #msg-95510779
MYOG GILD 50% $2.5B 10/06 #msg-13712121
MIL Merck KGaA 50% $7.2B 3/10 #msg-47249493
CRGN CLDX 50% $40M 5/09 #msg-38262967
TNOX DNA 50% $919M 11/06 #msg-14673162
SURG VRX 48% $166M 9/15 #msg-116690920
BEC Danaher 46% $6.8B 2/11 #msg-59624646
PHRM CELG 46% $2.9B 11/07 #msg-24645394
ROCM BCR 45% $262M 9/13 #msg-91684202
ZSPH AZN 42% $2.7B 11/15 #msg-118292261
ASPX TEVA 42% $3.2B 3/15 #msg-112224762
CALP PKI 42% $600M 9/11 #msg-66915400
BRL TEVA 42% $9.0B 7/08 #msg-30792830
VITA SYK 41% $320M 5/11 #msg-63178312
AGAM STJ 41% $1.3B 10/10 #msg-55673504
PATH TEVA 40% s$144M 1/14 #msg-96147237
SLTM VRX 40% $236M 12/13 #msg-95003986
KG PFE 40% $3.6B 10/10 #msg-55425514
PCYC ABBV n39% $21B 3/15 #msg-111425234
SYR.L STE 39% $1.9B 10/14 #msg-107152734
HSP PFE 39% $17B 2/15 #msg-110577169
MRX VRX 39% $2.6B 9/12 #msg-79186818
CEPH TEVA 39% $6.8B 5/11 #msg-62636692
ORCH LH 39% $85M 4/11 #msg-61801828
MOGN Eisai 39% $3.9B 12/07 #msg-25163775
BXLT SHPG 38% $32B 1/16 #msg-119743932
ITMN Roche 38% $8.3B 8/14 #msg-105603127
SNTS SLXP 38% $2.6B 11/13 #msg-93839578
ONXX AMGN 38% $9.7B 8/13 #msg-91383118
LIFE TMO 38% $15.6B 4/13 #msg-86836458
DUSA Sun Pharma 38% $230M 11/12 #msg-81273572
STJ ABT 37% $30.7B 4/16 #msg-122251293
CBST MRK 37% $9.5B 12/14 #msg-108853418
SIAL Merck KGaA 37% $17B 9/14 #msg-106484466
PRX TPG (prvt) 37% $1.9B 7/12 #msg-77533202
MTOX LH 37% $240M 6/12 #msg-76240732
GENZ SNY v37% v$20.1B 2/11 #msg-59975091
DYAX SHPG 35% $5.9B 11/15 #msg-118164544
MATK Royal DSM 35% $1.1B 12/10 #msg-57987049
WCRX ACT 34% $8.5B 5/13 #msg-88088454
AMMD ENDP 34% $2.9B 4/11 #msg-61948007
CLRT GE 34% $580M 10/10 #msg-55864640
SGP MRK 34% $41B 3/09 #msg-36140327
HTRN ENDP 34% $223M 5/10 #msg-49838813
AKGZF Bayer 33% $2.9B 12/13 #msg-95174198
KNSY Royal DSM 33% $360M 5/12 #msg-75204020
MITI AMGN 33% $1.16B 1/12 #msg-71341339
CVD LH 32% $5.6B 11/14 #msg-107784169
SMTS COV 32% $250M 6/10 #msg-51344183
TOMO ARAY 31% $277M 3/11 #msg-60697854
THOR STJ 30% $3.4B 7/15 #msg-115599422
PPDI CarlyleGrp 30% $3.9B 10/11 #msg-67625255
OctoPlus RDY 30% $35M 10/12 #msg-80752228
CGPI Galderma 30% $420M 2/08 #msg-28286522
COV MDT 29% $42.9B 6/14 #msg-103352775
CHTP Lundbeck 29% $530M 5/14 #msg-101687352
WYE PFE 29% $68B 1/09 #msg-35077617
APPX Fresenius 29% $940M 7/08 #msg-30498388
CRA DGX 28% $330M 3/11 #msg-61103240
SEPR Dainippon 28% $2.6B 9/09 #msg-41143301
AGN PFE †27% $160B 11/15 #msg-118690073
QCOR MNK 27% $5.6B 4/14 #msg-100144844
CNJ.TO EBS 27% $222M 12/13 #msg-94886880
GIVN COV 27% $860M 12/13 #msg-94759019
VPHM Shire 27% $4.2B 11/13 #msg-93924184
ASTX Otsuka 27% $886M 9/13 #msg-91706292
ALTH SPPI 27% $108M 4/12 #msg-74081029
GXDX NVS 27% $330M 1/11 #msg-59092015
LBMH BCR 26% $181M 11/15 #msg-118658269
CFN BD 26% $12.2B 10/14 #msg-106924866
CADX MNK 26% $1.3B 2/14 #msg-97103062
ISPH MRK 26% $430M 4/11 #msg-61724403
Zentiva SNY 26% $2.6B 9/08 #msg-32327005
SLXP VRX p25% $15.9B 3/15 #msg-111768607
FRX ACT 25% $25B 2/14 #msg-97422529
ICOS LLY 25% $2.3B 12/06 #msg-15623908
KYTH AGN 24% $2.1B 6/15 #msg-114667193
HITK AKRX 24% $540M 8/13 #msg-91428592
ZOLL AsahiKasei 24% $2.2B 3/12 #msg-73194976
NOVN Hisamitsu 22% $428M 7/09 #msg-39515681
DNEX TMO 21% $2.1B 12/10 #msg-57686719
PLB.TO ENDP 20% $74M 11/13 #msg-93718507
CPTS Bayer 20% $1.1B 4/13 #msg-87353545
PBTH OPK 20% $480M 4/13 #msg-87185863
GPRO HOLX 20% $3.7B 4/12 #msg-74999864
FURX FRX 19% $1.1B 4/14 #msg-101191792
CLDA FRX 19% $1.2B 2/11 #msg-60171753
PPCO ENDP 19% $168M 8/10 #msg-53137069
EVVV COV 19% $2.6B 6/10 #msg-50797343
RCPT CELG 18% $7.2B 7/15 #msg-115406201
KCI Apax Prts 17% $6.3B 7/11 #msg-65162696
ABII CELG 17% $2.9B 6/10 #msg-51844360
ACL NVS x17% x$49.7B 1/10 #msg-45072999
AEGR QLTI m16% $45M 6/16 #msg-123312384
KMNS XIO Grp 16% $510M 6/15 #msg-114711266
PRXN.L Upshr-Smth 16% $350M 6/12 #msg-76556065
CGRB JNJ 16% $970M 5/09 #msg-38039851
DNA Roche 16% w$46.8B 3/09 #msg-36224175
TSRX CBST 15% $707M 7/13 #msg-90492857
ARI.to Roche 15% $190M 7/08 #msg-30904056
FEIC TMO 14% $4.2B 5/16 #msg-122953139
SENO BCR 14% $213M 5/10 #msg-49838776
AVNR Otsuka 13% $3.5B 12/14 #msg-108677894
WX pvt grp 11% $3.3B 8/15 #msg-116208102
ELN PRGO 11% $6.7B 7/13 #msg-90418077
TGX Juniper 9% $52M 8/13 #msg-90677660
EURX Axcan 9% $583M 12/10 #msg-57543845
HPTX HZNP 8% $1.1B 3/15 #msg-112225598
PMTI CYNO 8% $294M 3/13 #msg-85810217
ARTC SN.L 6% $1.7B 2/14 #msg-96750072
CEGE BPAX 6% $38M 6/09 #msg-39163410
MEND JNJ 6% $480M 7/10 #msg-52176337
PRON.OL BASF 4% $844M 12/12 #msg-81711876
GENT JAZZ 2% $1.0B 12/13 #msg-95143526
CRTX Chiesi (3%) t$106M 9/13 #msg-92046498
VXGN OXGN (4%) $33M 10/09 #msg-42578130
AVGN MNOV (7%) $38M 8/09 #msg-40769841
VRX BVF (7%) $3.9B 6/10 #msg-51505172
OPTR CBST (19%) $535M 7/13 #msg-90492857
TLON SPPI ‡(85%) ‡$11M 7/13 #msg-90020541
CBYL KalVista ® ® 6/16 #msg-123315137
BIOD ALBO ® ® 5/16 #msg-122880969
SNTA Madrigal ® ® 4/16 #msg-121919321
APPY Strand LS ® ® 1/16 #msg-120095130
RESX Diffusion ® ® 1/16 #msg-119714298
CLDN Eiger ® ® 11/15 #msg-118623913
SVACF VBI ® ® 10/15 #msg-120043416
CLTX Volution ® ® 7/15 #msg-115354702
RTGN PULM ® ® 6/15 #msg-114559267
TBUFF POZN ® ® 6/15 #msg-114404029
DARA MTPH.L ® ® 6/15 #msg-114299115
TRGT Catalyst ® ® 3/15 #msg-111461780
RGDO Tobira ® ® 1/15 #msg-109912303
TKMR OnCore ® ® 1/15 #msg-109820030
TSPT Paratek ® ® 7/14 #msg-103895855
TELK MabVax ® ® 5/14 #msg-101987443
ZLCS Epirus ® ® 4/14 #msg-100707725
NABI Biota ® ® 11/12 #msg-81312718
TRMS Synageva ® ® 6/11 #msg-64249161
PGLA Avexa ® ® 12/08 #msg-34341452
NUVO ARCA ® ® 9/08 #msg-32420015
NOVC TSPT ® ® 9/08 #msg-31869987
VSGN IPC ® ® 8/09 #msg-40603745
‡ Relative to “unaffected” share price in cases where
a buyout offer or auction was made public; excludes
contingent values unless otherwise specified.
* Adjusted for cash/debt on acquired company’s balance sheet.
† Relative to AGN’s share price on 10/28/15.
® Reverse merger; premium not calculable.
m Merged company to be named Novelion.
n Premium relative to 2/24/15 (before leak of buyout bidding war).
p Premium relative to 8/18/14 (before speculation re AGN takeover).
q Premium relative to 4/10/14 (before Pershing Sq accumulation).
s Premium excludes contingent fees and is calculated from
12/13/13 close, the day before ENDP offer.
t For 42% of company not already owned.
u Includes $1.7B assumption of debt; premium relative to
3/27/12 close, when Bloomberg reported BMY bid. AZN pays
BMY $3.4B to put AMLN’s portfolio into 50/50 JV.
v Excluding CVR of $4-14/sh; premium relative to 7/22/10 close.
w For 44% of DNA not already owned.
x Price includes entire deal in three stages; 17% premium is the
blended avg price of NVS’ purchases ($164) relative to ACL’s market
price 4/4/08 immediately prior to announcement of first stage of deal.
y Includes $0.45/sh of contingent payments.
z Liquidated by Deerfield following failed merger with Archemix.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Get a bag of popcorn and watch the show.
scion Member Level Tuesday, 06/21/16 02:17:54 PM
Re: scion post# 109524
Post # of 109549
Massachusetts Federal Court Sentences Defendant in SEC Microcap Manipulation Case to 42 Months Imprisonment
U.S. SECURITIES AND EXCHANGE COMMISSION
Litigation Release No. 23576 / June 21, 2016
Securities and Exchange Commission v. Michael Affa, et al., No. 14-cv-12959 (D. Mass. filed July 11, 2014)
United States v. Mitchell Brown, Nos. 1:14-cr-10221 and 1:14-cr-10297 (D. Mass.)
Massachusetts Federal Court Sentences Defendant in SEC Microcap Manipulation Case to 42 Months Imprisonment
The Securities and Exchange Commission announced that on June 20, 2016, a federal court in Boston, Massachusetts sentenced Mitchell H. Brown, of Long Branch, New Jersey, to 42 months in prison and 3 years of supervised release, and ordered him to pay a fine of $1 million in two separate criminal cases. Brown also was ordered to pay restitution of $ 420,643. Brown pleaded guilty in September 2015 to conspiracy, securities fraud and wire fraud for his participation with four other defendants in a pump-and-dump scheme in the securities of Boston-based Amogear Inc. and in December 2015 for his participation in another pump-and-dump scheme.
The criminal case was announced the same day as SEC fraud charges against Brown and the other four defendants for attempting to manipulate shares of Amogear that was caught by an FBI undercover operation. According to the SEC's complaint filed in federal court in Boston, the defendants knew that Amogear was a shell company without any real operations but schemed to boost its price and profit by selling their own shares. What the defendants did not know was that the FBI controlled Amogear and used it to obtain evidence of attempted stock manipulation. To protect investors, the SEC suspended trading in Amogear's securities on February 10, 2014 as the attempted stock manipulation was underway.
In March 2016, the federal court in the SEC's case entered judgments by consent against all five defendants, enjoining them from violating Section 17(a)(1) and (3) of the Securities Act of 1933, Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5(a) and (c) thereunder, and prohibiting them from participating in any offering of penny stock, pursuant to Section 21(d)(6) of the Exchange Act.
Michael A. Affa, one of Brown's co-defendants, also was charged criminally and was sentenced in February 2016 to 33 months in prison and ordered to pay a fine of $1 million; the other defendants await sentencing.
For further information, see Litigation Release Nos. 23495 (Mar. 23, 2016), 23469 (Feb. 17, 2016), Press Release No. 2014-135 (July 11, 2014), and Exchange Act Release No. 71514 (Feb. 10, 2014).
The Judge came down hard on him. He received an additional 6 months in the BOP than the others. A MILLION DOLLAR FINE OUCH!
Sentencing of Mitchell Brown
scion Member Level Tuesday, 06/21/16 09:09:57 AM
Re: scion post# 108956
Post # of 109530
Pacer update 21 Jun 16 - USA v. Affa et al CRIMINAL DOCKET FOR CASE #: 1:14-cr-10221
https://ecf.mad.uscourts.gov/cgi-bin/iquery.pl
Date Filed # Docket Text
06/20/2016 190 Electronic Clerk's Notes for proceedings held before Judge William G. Young: Sentencing held on 6/20/2016 for Mitchell Brown (3), Count(s) 1, 2, 3-7. The Court addresses the defendant, announces the average sentences and calculates the sentencing guidelines. After hearing from counsel, the Court accepts tender of guilty plea. After hearing from the defendant the Court imposes the following sentence: The defendant is committed to the custody of BOP for 42 months on each count, each count to run concurrently with each other and with term imposed in case 15-cr-10297-WGY. Three years of supervised release with standard and special conditions (concurrent with supervised release imposed in 15-cr-10297). $900 total special assessment (combined with 15-cr-10297). $1 Million fine (combined with fine imposed in 15-cr-10297). The Court adopts calculations in PSR. The defendant is notified of the right to appeal. Should an appeal be contemplated, the Court ORDERS the parties to move for the production of the necessary transcript, PRIOR to the filing of the notice of appeal. The defendant is released on the same conditions previously set and shall self report to the place of confinement on Tuesday, September 6, 2016. (Attorneys present: Ausa Thomadakis and Palid, Defense counsel Roth. )Court Reporter Name and Contact or digital recording information: Richard Romanow at bulldog@richromanow.com. (Gaudet, Jennifer) (Entered: 06/21/2016)
CRIMINAL DOCKET FOR CASE #: 1:14-cr-10221-WGY All Defendants
Case title: USA v. Affa et al
Magistrate judge case numbers: 1:14-mj-01051-RBC
1:14-mj-01052-RBC
1:14-mj-01053-RBC
1:14-mj-07112-JCB
Date Filed: 07/23/2014
Assigned to: Judge William G. Young
Defendant (1)
Michael Affa
TERMINATED: 02/19/2016
also known as
Michael A. Affa
TERMINATED: 02/19/2016
represented by Robert M. Goldstein
20 Park Plaza, Suite 1000
Boston, MA 02116
617-742-9015
Fax: 617-742-9016
Email: rmg@goldstein-lawfirm.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Retained
Pending Counts
Disposition
18:371...CONSPIRACY TO COMMIT SECURITIES FRAUD AND WIRE FRAUD
(1) The defendant is sentenced to 33 months in custody of Bureau of Prisons on each count, each count to run concurrently with each other, to be followed by 36 months of supervised release with standard and special conditions. $700 special assessment. $1,000,000 fine.
15:78j(b), 78(ff); 17 C.F.R. SEC. 240.10b5; AND 18:2...SECURITIES FRAUD
(2) The defendant is sentenced to 33 months in custody of Bureau of Prisons on each count, each count to run concurrently with each other, to be followed by 36 months of supervised release with standard and special conditions. $700 special assessment. $1,000,000 fine.
18:1343, 1349, AND 2...WIRE FRAUD
(3-7) The defendant is sentenced to 33 months in custody of Bureau of Prisons on each count, each count to run concurrently with each other, to be followed by 36 months of supervised release with standard and special conditions. $700 special assessment. $1,000,000 fine.
Highest Offense Level (Opening)
Felony
Terminated Counts
Disposition
None
Highest Offense Level (Terminated)
None
Complaints
Disposition
18:371 - CONSPIRACY
Assigned to: Judge William G. Young
Defendant (2)
Andrew Affa
also known as
Andrew J. Affa
represented by Steven E. Losquadro
649 Route 25A
Suite 4
Rocky Point, NY 11778
631-744-9070
Fax: 631-744-9421
Email: losquadrolaw@aol.com
LEAD ATTORNEY
PRO HAC VICE
ATTORNEY TO BE NOTICED
Designation: Retained
William H. Connolly
Law Offices of William H. Connolly
20 Park Plaza
Suite 1000
Boston, MA 02210
617-542-0200
Email: whc@williamconnollylaw.com
ATTORNEY TO BE NOTICED
Designation: Retained
Pending Counts
Disposition
18:371...CONSPIRACY TO COMMIT SECURITIES FRAUD AND WIRE FRAUD
(1)
15:78j(b), 78(ff); 17 C.F.R. SEC. 240.10b5; AND 18:2...SECURITIES FRAUD
(2)
18:1343, 1349, AND 2...WIRE FRAUD
(3-7)
Highest Offense Level (Opening)
Felony
Terminated Counts
Disposition
None
Highest Offense Level (Terminated)
None
Complaints
Disposition
18:371 - CONSPIRACY
Assigned to: Judge William G. Young
Defendant (3)
Mitchell Brown
also known as
Mitchell H. Brown
represented by Richard Roth
The Roth Law Firm, PLLC
295 Madison Avenue
Floor 22
New York, NY 10017
(212) 542-8882
Fax: (212) 542-8883
Email: rich@rrothlaw.com
LEAD ATTORNEY
PRO HAC VICE
ATTORNEY TO BE NOTICED
Designation: Retained
Danielle Pomeraniec
The Roth Law Firm, PLLC
295 Madison Avenue
Floor 22
New York, NY 10017
(212) 542-8882
Fax: (212) 542-8883
Email: danielle@rrothlaw.com
TERMINATED: 06/01/2015
PRO HAC VICE
ATTORNEY TO BE NOTICED
Designation: Retained
Robert S. Messinger
Nystrom Beckman & Paris LLP
One Marina Park Drive, 15th Flr.
Boston, MA 02210
617-778-9104
Fax: 617-778-9110
Email: robert.messinger@gmail.com
ATTORNEY TO BE NOTICED
Designation: Retained
Pending Counts
Disposition
18:371...CONSPIRACY TO COMMIT SECURITIES FRAUD AND WIRE FRAUD
(1)
15:78j(b), 78(ff); 17 C.F.R. SEC. 240.10b5; AND 18:2...SECURITIES FRAUD
(2)
18:1343, 1349, AND 2...WIRE FRAUD
(3-7)
Highest Offense Level (Opening)
Felony
Terminated Counts
Disposition
None
Highest Offense Level (Terminated)
None
Complaints
Disposition
18:371 - CONSPIRACY
Assigned to: Judge William G. Young
Defendant (4)
Christopher Putnam
also known as
Christopher R. Putnam
represented by Joshua Robert Hanye
Federal Public Defender's Office
5th Floor
51 Sleeper Street
Boston, MA 02210
617-223-8061
Email: joshua_hanye@fd.org
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Public Defender or Community Defender Appointment
Pending Counts
Disposition
18:371...CONSPIRACY TO COMMIT SECURITIES FRAUD AND WIRE FRAUD
(1)
15:78j(b), 78(ff); 17 C.F.R. SEC. 240.10b5; AND 18:2...SECURITIES FRAUD
(2)
18:1343, 1349, AND 2...WIRE FRAUD
(3-7)
Highest Offense Level (Opening)
Felony
Terminated Counts
Disposition
None
Highest Offense Level (Terminated)
None
Complaints
Disposition
18 U.S.C. § 371 Conspiracy to Commit Securities Fraud.
Assigned to: Judge William G. Young
Defendant (5)
Christopher Nix
also known as
Gabe Nix
also known as
Christopher G. Nix
represented by Jonathan L. Kotlier
Nutter, McClennen & Fish, LLP
Seaport West
155 Seaport Boulevard
Boston, MA 02210-2604
617-439-2000
Fax: 617-310-9683
Email: jkotlier@nutter.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Retained
Andrew R. McArdell
Nutter, McClennen & Fish, LLP
Seaport West
155 Seaport Boulevard
Boston, MA 02210-2604
617-439-2339
Email: amcardell@nutter.com
ATTORNEY TO BE NOTICED
Designation: Retained
Pending Counts
Disposition
18:371...CONSPIRACY TO COMMIT SECURITIES FRAUD AND WIRE FRAUD
(1)
15:78j(b), 78(ff); 17 C.F.R. SEC. 240.10b5; AND 18:2...SECURITIES FRAUD
(2)
18:1343, 1349, AND 2...WIRE FRAUD
(3-7)
Highest Offense Level (Opening)
Felony
Terminated Counts
Disposition
None
Highest Offense Level (Terminated)
None
Complaints
Disposition
18 U.S.C. § 371 Conspiracy to Commit Securities Fraud.
Plaintiff
USA
represented by Eric A. Forni
United States Attorney's Office MA
Suite 9200
1 Courthouse Way
Boston, MA 02210
617-573-8827
Email: eric.forni@usdoj.gov
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Assistant US Attorney
Vassili Thomadakis
US Attorney's Office - MA
J. Joseph Moakley U.S. Courthouse
1 Courthouse Way
Suite 9200
Boston, MA 02210
617-748-3248
Email: vassili.thomadakis@usdoj.gov
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Assistant US Attorney
Andrew J. Palid
Securities and Exchange Commission - MA
33 Arch Street
23rd Floor
Boston, MA 02110-1424
(617) 573-4540
Email: palida@sec.gov
ATTORNEY TO BE NOTICED
https://ecf.mad.uscourts.gov/cgi-bin/iquery.pl
That's a first hand look at what a low life crook Mitch Brown is!